$2.04
-0.11-5.12%
Last update: Oct 1, 4:56 PM
$2.07
-0.08-3.72%
Grace Therapeutics Inc
GRCENASDAQ
Grace Therapeutics (GRCE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.18 | $-0.21 | $-0.27 | $-0.25 |
| Actual | $-0.91 | $-0.06 | $-0.14 | $-0.06 |
| Surprise | -405.6% | +71.4% | +48.1% | +76.0% |
| Revenue | ||||
| Estimate | $545000 | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | — | — | — |
| Metric | Q2 '27E | Q3 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.21 | $-0.21 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | Aug 13, 2026 | $-0.91 | $-0.18 | -405.6 % |
| Q4 | Jun 18, 2026 | $-0.06 | $-0.21 | 71.4 % |
| Q3 | Feb 12, 2026 | $-0.14 | $-0.27 | 48.1 % |
| Q2 | Nov 13, 2025 | $-0.06 | $-0.25 | 76.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | Aug 13, 2026 | $0 | $545.00K | -100.0 % |
